Fitness cost of drug resistance inMycobacterium tuberculosis
- 1 January 2009
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 15 (s1) , 66-68
- https://doi.org/10.1111/j.1469-0691.2008.02685.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- XDR Tuberculosis — Implications for Global Public HealthNew England Journal of Medicine, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaPublished by Elsevier ,2006
- The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosisScience, 2006
- Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosisPLoS Pathogens, 2006
- Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitnessNature Medicine, 2004
- Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistanceNature Medicine, 2004
- Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolutionResearch in Microbiology, 2004
- Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in HumansInfection and Immunity, 2002
- Humans as the World's Greatest Evolutionary ForceScience, 2001
- Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosisMolecular Microbiology, 1995